The legal library gives you easy access to the FTC’s case information and other official legal, policy, and guidance documents.
20050435: MTC Technologies; Dr. Paul Hsu and Majes Hsu
20050424: Moulin International Holdings Limited; Thomas H. Lee Equity Fund IV, L.P.
20050439: UBS AG; Julius Baer Holding Ltd.
20050426: Highmark, Inc.; Harvey Ross
West Coast Advertising & Marketing, Inc.; et al.
Granting of Request for Early Termination of the Waiting Period Under the Premerger Notification Rules
Notice of Intent to Request Public Comments - 16 CFR Chapter 1
0501003 Informal Interpretation
Cephalon, Inc., and CIMA Labs, Inc.
The consent order settled charges that Cephalon's proposed acquisition of Cima Labs, Inc. would allow Cephalon to continue its monopoly in the United States market for drugs that eliminate or reduce the spikes of severe pain that chronic cancer patients experience. The consent order required Cephalon to grant Barr Laboratories, Inc. a fully paid, irrevocable license to make and sell a generic version of Cephalon's breakthrough cancer pain drug, Actiq, in the United States.